Everest Re Group, Ltd. RE is slated to report second-quarter 2019 results on Jul 29 after market close. The company delivered positive surprise in three of the last four reported quarters.Factors to ConsiderEverest Re’s second-quarter results are likely to benefit from its global presence, product diversification, capital adequacy, financial flexibility and traditional risk management capabilities.The Insurance segment is likely to benefit from product diversification, staffing up of underwriting operations, international insurance growth and ramp up of Canadian and European platforms. The Lloyds platform should also add to the upside. The Zacks Consensus Estimate for premiums earned is pegged at $462 million.The Reinsurance segment is likely to benefit from growth initiatives including deployment of increased capacity to pro-rata deal, which has attractive original pricing terms and conditions.Better pricing at property and commercial auto books as well as primary general liability and various professional lines should aid premium. However, in U.S. workers' compensation, rate pressure persists.Improved rate environment and higher asset base is likely to aid net investment income. The company expects improvement in limited partnership income, given improvement in public equity market trading conditions.A benign catastrophe environment is likely to aid underwriting profitability. The Zacks Consensus Estimate for combined ratio is pegged at 92%, indicating an improvement of 1300 basis points from the year-ago period reported figure.The Zacks Consensus Estimate is pegged at $6.66 per share, indicating 579.6% year-over-year increase.What Our Quantitative Model SaysOur proven model shows that Everest Re is likely to beat estimates in the to-be-reported quarter. This is because it has the right combination of a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold).Earnings ESP: Everest Re has an Earnings ESP of +0.53% as the Most Accurate Estimate of $6.70 is more than the Zacks Consensus Estimate of $6.66. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.Everest Re Group, Ltd. Price and EPS Surprise Everest Re Group, Ltd. price-eps-surprise | Everest Re Group, Ltd. QuoteZacks Rank: Everest Re carries a Zacks Rank #2.Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks should never be considered going into an earnings announcement, especially when the company is seeing negative estimate revisions.Other Stocks to ConsiderSome other stocks from the insurance industry with the right combination of elements to surpass estimates this time around are as follows:Markel Corporation MKL is set to report second-quarter earnings on Jul 30. The company has an Earnings ESP of +1.60% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.The Hartford Financial Services Group, Inc. HIG has an Earnings ESP of +0.63% and a Zacks Rank of 3. The company is scheduled to release second-quarter earnings on Aug 1.Alleghany Corporation Y has an Earnings ESP of +1.74% and a Zacks Rank of 3. The company is scheduled to release second-quarter earnings on Aug 6.This Could Be the Fastest Way to Grow Wealth in 2019Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.Click here to see these breakthrough stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Hartford Financial Services Group, Inc. (HIG): Free Stock Analysis Report Alleghany Corporation (Y): Free Stock Analysis Report Markel Corporation (MKL): Free Stock Analysis Report Everest Re Group, Ltd. (RE): Free Stock Analysis Report To read this article on Zacks.com click here.